ストックスクリーナーアプリを入手
1.71
2.29%
-0.04
アフターアワーズ：
1.69
-0.02
-1.17%
前日終値:
$1.75
開ける：
$1.77
24時間の取引高:
158.21K
Relative Volume:
0.70
時価総額：
$27.48M
収益：
-
当期純損益:
$-8.29M
株価収益率:
-2.4429
EPS:
-0.7
ネットキャッシュフロー:
$-6.47M
1週間 パフォーマンス:
+4.27%
1か月 パフォーマンス:
+22.14%
6か月 パフォーマンス:
+54.05%
1年 パフォーマンス:
-31.33%
1日の値動き範囲:
$1.66
$1.77
1週間の範囲:
$1.54
$1.78
52週間の値動き範囲:
$0.94
$2.50
NanoViricides Inc Stock (NNVC) Company Profile
NNVC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.71 | 27.32M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-02-11 | 開始されました | Midtown Partners | Strong Buy |
NanoViricides Inc (NNVC) 最新ニュース
NanoViricides Discusses the Multi-Billion-Dollar Potential of Its Broad-Spectrum Drug NV-387; Its Effectiveness Against Influenza, Coronaviruses, RSV, MPox and Now Measles Expected to Drive Value - Greenville Online
What drives NanoViricides Inc. stock priceMarket-crushing stock picks - Autocar Professional
NanoViricides eyes revenue opportunities with broad-spectrum antiviral NV-387 - Proactive financial news
Multi-Billion Dollar Opportunity: NanoViricides' New Drug Fights COVID, Flu, RSV and Measles with Single Treatment - Stock Titan
NanoViricides Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com
How NanoViricides Inc. stock performs during market volatilityFree Consultation - Newser
What analysts say about NanoViricides Inc. stockStrongest growth potential - jammulinksnews.com
Is NanoViricides Inc. a good long term investmentOutstanding capital appreciation - jammulinksnews.com
Measles Now Has a DrugNV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides - Lohud
NanoViricides says lead antiviral boosted survival in measles-infected mice - Proactive financial news
Mpox Antiviral Clinical Trial Advances as WHO Extends Global Emergency - Global Biodefense
WHO Extended Global Emergency Status of MPox EpidemicDevelopment of Treatment for MPox with NV-387 is Timely, Says NanoViricides - Pocono Record
NanoViricides Advances MPox Treatment Development Amid WHO's Extended Health Emergency - citybuzz -
NanoViricides says MPox drug candidate NV-387 poised for Phase II trial as WHO extends global health emergency - Proactive financial news
D.C. United Roofing Inc. Wins 2025 Consumer Choice Award for Roofing in Barrie - The Palm Beach Post
NanoViricides Targets Multi-Billion MPox Market with Superior Treatment as WHO Extends Global Emergency - Stock Titan
Go Industries Inc. Unveils Durable Winch Grille Guard for Unmatched Vehicle Protection - The Palm Beach Post
What makes NanoViricides Inc. stock price move sharplyReal Time Breakout Tracking - Newser
Why NanoViricides Inc. stock attracts strong analyst attention3x Return Stock Radar - Newser
NanoViricides positioned at forefront of Mpox treatment efforts, says Zacks - Proactive financial news
NanoViricides Inc (NNVC) 財務データ
収益
当期純利益
現金流量
EPS
3.32%
1.57%
大文字化:
|
ボリューム (24 時間):